These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26889216)

  • 1. Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysis.
    Liu Y; Xiao J; Shi X; Hao G; Chen Q; Zhou J; Wei X
    Exp Ther Med; 2016 Jan; 11(1):49-56. PubMed ID: 26889216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive agents in the treatment of IgA nephropathy: A meta-analysis of clinical randomized controlled literature.
    Zheng J; Gong X; Wu Z
    Niger J Clin Pract; 2020 Apr; 23(4):437-449. PubMed ID: 32246648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive agents for treating IgA nephropathy.
    Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults.
    Xie G; Xu J; Ye C; Chen D; Xu C; Yang L; Ma Y; Hu X; Li L; Sun L; Zhao X; Mao Z; Mei C
    PLoS One; 2012; 7(9):e44330. PubMed ID: 22957065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Immunosuppressive Monotherapy Agents for IgA Nephropathy: A Network Meta-Analysis.
    Han S; Yao T; Lu Y; Chen M; Xu Y; Wang Y
    Front Pharmacol; 2020; 11():539545. PubMed ID: 33551793
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of immunosuppressive treatment in IgA nephropathy: a meta-analysis of randomized controlled trials.
    Zhang Z; Yang Y; Jiang SM; Li WG
    BMC Nephrol; 2019 Aug; 20(1):333. PubMed ID: 31455248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of mycophenolate mofetil for IgA nephropathy: An updated meta-analysis of randomized controlled trials.
    Zheng JN; Bi TD; Zhu LB; Liu LL
    Exp Ther Med; 2018 Sep; 16(3):1882-1890. PubMed ID: 30186414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Patients with IgA Nephropathy: Evaluation of the Safety and Efficacy of Mycophenolate Mofetil.
    Chen Z; Chen W; Zheng L; Xie Y; Yao K; Zhou T
    Curr Pharm Des; 2024; 30(30):2400-2409. PubMed ID: 38988169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of immunosuppressive therapies in the treatment of high-risk IgA nephropathy: A network meta-analysis.
    Liu T; Wang Y; Mao H; Yang L; Zhan Y
    Medicine (Baltimore); 2021 Feb; 100(8):e24541. PubMed ID: 33663060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive agents for treating IgA nephropathy.
    Samuels JA; Strippoli GF; Craig JC; Schena FP; Molony DA
    Cochrane Database Syst Rev; 2003; (4):CD003965. PubMed ID: 14584001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
    Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
    Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of calcineurin inhibitor treatment for IgA nephropathy: a meta-analysis.
    Song YH; Cai GY; Xiao YF; Wang YP; Yuan BS; Xia YY; Wang SY; Chen P; Liu SW; Chen XM
    BMC Nephrol; 2017 Feb; 18(1):61. PubMed ID: 28193247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of immunosuppressive therapies in the treatment of IgA nephropathy: A network meta-analysis.
    Tan J; Dong L; Ye D; Tang Y; Hu T; Zhong Z; Tarun P; Xu Y; Qin W
    Sci Rep; 2020 Apr; 10(1):6062. PubMed ID: 32269271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM; Wong SC; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD003594. PubMed ID: 27726125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil treatment for IgA nephropathy: a meta-analysis.
    Xu G; Tu W; Jiang D; Xu C
    Am J Nephrol; 2009; 29(5):362-7. PubMed ID: 18974636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of effects and safety of Tripterygium wilfordii polyglycoside in the treatment of IgA nephropathy.
    Wang RX; Liao BQ; Chen W; Zhang YM; Tang XH; Xie FH
    Eur Rev Med Pharmacol Sci; 2022 Dec; 26(23):8756-8770. PubMed ID: 36524494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of angiotensin-converting enzyme inhibitors/angiotensin receptor blocker therapy for IgA nephropathy: A meta-analysis of randomized controlled trials.
    Ji Y; Yang K; Xiao B; Lin J; Zhao Q; Bhuva MS; Yang H
    J Cell Biochem; 2019 Mar; 120(3):3689-3695. PubMed ID: 30270542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of leflunomide in IgA nephropathy: a systematic review and meta-analysis.
    Yi J; He Z; Xu S; Feng S
    Int Urol Nephrol; 2019 Nov; 51(11):1987-1998. PubMed ID: 31515666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of Tripterygium wilfordii Hook F in the immunosuppressive treatment of IgA nephropathy.
    Chen YZ; Gao Q; Zhao XZ; Chen XM; Zhang F; Chen J; Xu CG; Sun LL; Mei CL
    Intern Med; 2010; 49(19):2049-55. PubMed ID: 20930429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of glucocorticoids for patients with IgA nephropathy: a meta-analysis.
    Qian G; Zhang X; Xu W; Zou H; Li Y
    Int Urol Nephrol; 2019 May; 51(5):859-868. PubMed ID: 30843135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.